Florida S1638 prohibits discriminatory practices against 340B entities and drugs.
Florida S1638, known as the "Defending Affordable Prescription Drug Costs Act," aims to prohibit discriminatory practices against 340B entities and drugs. The bill defines "340B drug" as a drug subject to reduced prices by a manufacturer under the 340B Drug Pricing Program. It prohibits insurers, pharmacy benefit managers, and other third-party payors from reimbursing 340B entities at lower rates, imposing additional requirements, or excluding them from networks. Violators face penalties under the Florida Deceptive and Unfair Trade Practices Act.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.